Lv12
60 积分 2025-05-02 加入
Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis
1天前
已完结
First US drug approved for a liver disease surging around the world
1个月前
已完结
Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice
2个月前
已完结
Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1
2个月前
已完结
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
4个月前
已完结
皖公网安备34019202002308
